PPARgamma Modulates CD4+ T-Cell Differentiation and Allergic Inflammation in Allergic Rhinitis: A Potential Therapeutic Target
Open Access
- 1 July 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (7) , 1616
Abstract
Objectives: Given the emerging role of peroxisome proliferator-activated receptor gamma (PPARgamma) in immune regulation and the increasing prevalence of allergic rhinitis (AR), we sought to understand how modulation of the PPARgamma pathway impacts the balance of CD4+ T-cell subsets, particularly regulatory T cells (Tregs) and T helper (TH)1, TH2, and TH17 cells, which are key players in the pathogenesis of AR. This knowledge is crucial for developing novel therapeutic strategies targeting the PPARgamma-CD4+ T-cell axis to manage AR more effectively. Methods: We used PPARgammaf/fLyz2-Cre mice for PPARgamma deletion. In an ovalbumin (OVA)-induced AR mouse model, PPARgamma+/-f/fLyz2-Cre mice were assessed for allergic symptoms, splenic Tregs, and nasal eosinophils. Additionally, the effects of a PPARgamma agonist on the polarization of naïve CD4+ T cells were examined. Results: PPARgamma+/-f/fLyz2-Cre mice showed worsened allergic symptoms, reduced splenic Tregs, and increased nasal mucosa eosinophilic infiltration. PPARgamma agonist treatment promoted naïve CD4+ T-cell polarization into Tregs and inhibited their differentiation into TH1, TH2, and TH17 subsets. Conclusions: Our findings indicate that PPARgamma plays a crucial role in regulating TH-cell subsets in AR. PPARgamma agonists could be a potential therapeutic strategy to mitigate allergic inflammation in AR by promoting Treg development and suppressing pathogenic TH-cell responses.Keywords
Funding Information
- Shanghai Pudong New Area Health Commission (PW2023A-46)
This publication has 31 references indexed in Scilit:
- IL-17-Related Pathways and Myeloid Cell Function are Involved in the Mechanism of Sublingual Immunotherapy with Artemisia annua for Seasonal Allergic RhinitisClinical Reviews in Allergy & Immunology, 2025
- Increased circulating LOX-1+ neutrophils activate T cells and demonstrate a pro-inflammatory role in allergic rhinitisHeliyon, 2024
- Three Artemisia pollens trigger the onset of allergic rhinitis via TLR4/MyD88 signaling pathwayMolecular Biology Reports, 2024
- The Role of PPAR-γ in Allergic DiseaseCurrent Allergy and Asthma Reports, 2021
- Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidenceJournal of Allergy and Clinical Immunology, 2020
- Self-regulation of the inflammatory response by peroxisome proliferator-activated receptorsInflammation Research, 2019
- Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revisionJournal of Allergy and Clinical Immunology, 2017
- Activation of PPARγ inhibits pro-inflammatory cytokines production by upregulation of miR-124 in vitro and in vivoBiochemical and Biophysical Research Communications, 2017
- Antidiabetic agents: Potential anti-inflammatory activity beyond glucose controlDiabetes & Metabolism, 2015
- Regulation of TH17 markers early in life through maternal farm exposureJournal of Allergy and Clinical Immunology, 2014